Vimarsana
Biggest News Aggregation in the World

Alfred Garfall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alfred Garfall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alfred Garfall Today - Breaking & Trending Today

Ongoing Research Aims to Use Bispecific Antibodies in Earlier Settings and Novel Combinations in Myeloma - Vimarsana News

Ongoing Research Aims to Use Bispecific Antibodies in Earlier Settings and Novel Combinations in Myeloma

Joshua Richter, MD, provides an overview of the current state of bispecific antibodies in multiple myeloma, discusses ongoing investigations of these agents, and expands on their unique toxicities and the need for proactive management.

Novel Agents Highlight Changes in Myeloma Field - Vimarsana News

Novel Agents Highlight Changes in Myeloma Field

Leading investigators in the multiple myeloma field discuss the latest clinical trial findings, many of which were presented during the 2023 ASCO Annual Meeting.

Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients - Vimarsana News

Penn Medicine Awarded $14 Million NIH Grant to Apply CAR T Immunotherapies to Match More Patients

Vijay Bhoj, MD (left) and Ali Naji, MD (right) PHILADELPHIA – Penn Medicine has been awarded a prestigious seven-year, $14 million grant from the

Clinical Challenges: Options for Triple-Class Refractory Myeloma - Vimarsana News

Clinical Challenges: Options for Triple-Class Refractory Myeloma

Clinical decisions must weigh patient's goals, ability to handle available treatment strategies

Integrated Medical Communications Launches New Quarterly Print Publication - Vimarsana News

Integrated Medical Communications Launches New Quarterly Print Publication

Integrated Medical Communications Launches New Quarterly Print Publication Share Article Multiple Myeloma Today Offers a Deep Dive into Myeloma Research for Hematologists and Oncologists I’m proud that The Leukemia & Lymphoma Society (LLS) asked me to be the editor-in-chief of the LLS section of Multiple Myeloma Today,” said Saad Usmani, M.D. “More than ever, we need this type of publication to share updates on the research advances in the field, which are coming at a rapid pace. CLIFTON, N.J. (PRWEB) April 19, 2021 Integr...

Source: prweb.com